Our CEO Daniele Foresti is excited to be back in his home country, Italy, for the Italian Tech Weekend.
A great opportunity to connect with international and Italian startup and VC community to talk about current and future trends in innovation and tech
italiantechweek.com/en
AcousticaBio retweeted
Thank you for highlighting our work, which was led by Daniele Foresti. He co-founded @AcousticaBio to harness this advance for drug delivery🙏
Felt like honoring some more cool research. Here's a semi-oldie, but goodie from @JenniferALewis1 lab. Here, acoustic and gravitational forces work together to eject precise microliter-to-nanoliter droplets (from honey to liquid metal). Super useful! :)
science.org/doi/full/10.1126…
Join tomorrow the Lab-to-Launch Lounge by @innovationlab @hseas @HarvardTechXfer and hear from our CEO and Co-Founder Daniele Foresti, and Jasper Neggers, Founder and CSO of Promakhos Therapeutics, on how they launched their research out from Harvard labs
lab-to-launchlounge3.splasht…
AcousticaBio retweeted
Congratulations to @JenniferALewis1 and Pam Silver on being named Leading Innovators and Entrepreneurs to Follow by @bios_community on their list of Top Women Academic Entrepreneurs
#Entrepreneur #innovation #InternationalWomansDay2023
Beaker List 🔬 - Top 23 Female Academic Entrepreneurs
Happy International Women's Day! 🙌
Learn more about the female academic innovators behind the top translational labs generating the most impactful contributions to the life sciences ecosystem!
ow.ly/4SaB50NbGEV
AcousticaBio retweeted
Congratulations, Daniele Foresti @AcousticaBio 🌟
We're incredibly proud of the Wyss Lumineers Class of 2022! These entrepreneurial scientists commercialized technologies they developed at the Wyss and founded new startup companies within the last year. Join us in congratulating them!
wyss.harvard.edu/news/wyss-l…
Big shout out to our CEO and Founder Daniele Foresti for being nominated as one of the 2022 Wyss Lumineers!
Congratulations to the whole class of talents part of the Wyss Institute at Harvard University community
Congratulations to 2022 class of Wyss Lumineers! These community members embody our mission to transform healthcare and the environment by developing innovative technologies & accelerating their translation into commercial products through startups. wyss.harvard.edu/news/wyss-l…
AcousticaBio retweeted
Congratulations to 2022 class of Wyss Lumineers! These community members embody our mission to transform healthcare and the environment by developing innovative technologies & accelerating their translation into commercial products through startups. wyss.harvard.edu/news/wyss-l…
Louie believes Acoustica technology vastly expands the available biomaterials, biologics and polymerization strategies for developing new products for the life sciences
Meet the team: @EyalSRon, Board and Advisory Board member. Dr Ron is a visionary serial entrepreneur who led multiple start-ups from conception to exit. He creates tremendous value by effective mentoring while accelerating the timeline toward the value inflection points.
Dr. Ron facilitated the formation of Cerebrotec, Combinent Biomedical Systems, Sensei Biomaterials, just to name few. He thrives at the crossroad of drug eluting medical devices - a creative combination of pharmaceutical sciences with engineering.
Since his introduction to AcousticaBio’s team at the MassChallenge as a mentor, he was intrigued by the challenge of a large payload in a nano-engineered microsphere.
Fun Fact: Eyal has 4 bees hives and 5 chickens
#meettheteam #advisoryboard #Entrepreneur
Meet the Team: Jet Takayama, Operations Coordinator. Operations professional&graphic artist with a background in supply chain for tech. They have worked in supply chain&operations at RightHand Robotics,Amazon Prime Air, developing solutions at critical stages of company growth
AcousticaBio retweeted
Concertians, friends, mentors, and investors assembled for Gala_002 to celebrate our 2nd birthday. Cheers to our team—Ensemble No.1!—and our incredibly supportive ecosystem of humans!
Meet the team: Daniel Behr, Business Strategy Advisor. Daniel has been an entrepreneurial leader in startups, venture capital, university tech transfer. He has built new business opportunities and new ventures in biotech, material science, instrumentation, IT, textiles,clean tech
Daniel would love to see AcousticaBio succeed and improve the lives of millions of patients by replacing IV-delivered drugs (expensive, not self-administered, relatively painful) with subcutaneous injections (cost efficient, self administered, less painful)























